Book Building - SME
₹ - cr
₹ 0
-
₹ -
NSE - SME
-
-
-
Initial public offer of upto 25,52,000 equity shares of face value of Rs. 10/- each (the Equity Shares) of Genx Diagnostics Limited (The Company or GDL or The Issuer) at an issue price of Rs. [*] per equity share (including share premium of [*] per equity share) for cash, aggregating up to Rs. [*] crores (Public Issue) out of which [*]equity shares of face value of Rs. 10 each, at an issue price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (the Market Maker Reservation Portion). The public issue less market maker reservation portion i.e. issue of [*] equity shares of face value of Rs. 10 each, at an issue price of Rs. [*] per equity share for cash, aggregating upto Rs. [*] crores is herein after referred to as the Net Issue. The public issue and net issue will constitute 26.39% and [*]% respectively of the post-issue paid-up equity share capital of the company. The price band and the minimum bid lot will be decided by the company.
Funding capital expenditure for the isntallation of additional medical equipment at the existing diagnostics center. To finance the cost of establishing diagnostics centres Odisha,Chhattisgarh,Jharkhand and West Bengal. To finance the cost of establishing diagnostics collection centres across odisha. Repayment and/or pre-payment in full or part of certain borrowings availed by the company. To meet working capital requirements. General corporate purposes.
Genx Diagnostics Ltd, Office No 56-2, Pinnacle Busine.Park, Mahakali Caves Road, Mumbai - 400093
Phone - 91-22-62638200
Fax - 91-22-63638299
Email - cs@@genxlive.in
Website - www.genxlive.in